Invezz
Search documents
Apple chip chief Johny Srouji rejects exit rumors
Invezz· 2025-12-08 18:02
Apple's senior leadership ranks are undergoing their most significant upheaval in years, even as one of the company's most influential executives sought to halt speculation about his own future. Johny... ...
Nvidia stock in the green: what's happening with the ‘AI darling' today?
Invezz· 2025-12-08 17:40
Core Viewpoint - Nvidia's stock experienced a 0.4% increase on Monday, indicating positive investor sentiment ahead of an earnings report from competitor Broadcom, which specializes in artificial intelligence chips [1] Company Summary - Nvidia's stock performance is influenced by the upcoming earnings report from Broadcom, suggesting that investor sentiment is closely tied to developments in the AI chip sector [1] Industry Summary - The artificial intelligence chip market is competitive, with companies like Nvidia and Broadcom vying for investor attention and market share, highlighting the importance of earnings reports in shaping market dynamics [1]
Marvell stock: does the Microsoft news warrant trimming exposure?
Invezz· 2025-12-08 17:11
Marvell Technology (NASDAQ: MRVL) tanked more than 10% this morning following reports it could lose Microsoft (NASDAQ: MSFT) as an artificial intelligence (AI) customer. According to "The Information†... ...
CoreWeave stock is rising as technicals point to a drop to $50
Invezz· 2025-12-08 16:49
CoreWeave stock price has rebounded modestly in the past few days, moving from last month's low of $65.43 to the current $88. Still, the stock remains much lower than the year-to-date high of $186, me... ...
Structure Therapeutics stock: what's driving sudden 103% jump in GPCR shares?
Invezz· 2025-12-08 16:20
Core Insights - Structure Therapeutics' stock surged over 103% on Monday, reaching nearly $70, following the release of promising mid-stage results for its oral obesity drug, aleniglipron [1] Company Summary - Structure Therapeutics is a clinical-stage biotech company focused on developing innovative therapies, particularly in the area of obesity treatment [1] - The significant stock price increase reflects investor optimism regarding the efficacy of aleniglipron based on the recent clinical trial results [1] Industry Context - The biotech industry is witnessing heightened interest in obesity treatments, with companies exploring various therapeutic options to address this growing health concern [1] - The positive results from Structure Therapeutics may position the company favorably within a competitive market, potentially attracting further investment and partnerships [1]
Why Tesla stock is sliding over 3% on Monday
Invezz· 2025-12-08 16:14
Tesla stock fell sharply on Monday after Morgan Stanley stepped out of the bull camp, with its new lead analyst arguing that the company's valuation has run ahead of fundamentals. The decline also fol... ...
Battle for WBD not over: Paramount goes directly to shareholders with $108.4B all-cash hostile bid
Invezz· 2025-12-08 15:47
In a dramatic escalation of the battle for one of Hollywood's most storied studios, Paramount Skydance on Monday unveiled a $108.4 billion all-cash hostile bid for Warner Bros Discovery (WBD), just da... ...
Oracle stock forecast ahead of earnings as a bullish sign emerges
Invezz· 2025-12-08 15:30
Core Insights - Oracle's stock price has significantly declined from a year-to-date high of $345 in September to $217 currently, indicating a substantial market correction [1] - The market capitalization of Oracle has experienced a considerable drop, reflecting the impact of the stock price decline [1] Company Summary - The recent pullback in Oracle's stock price represents a major wipeout for the company, highlighting potential concerns among investors regarding its future performance [1]
US stocks open higher on tech strength with Fed rate-cut odds near 90%
Invezz· 2025-12-08 14:55
Core Viewpoint - US stocks experienced a slight increase on Monday, driven by a technology-led rally, alleviating concerns ahead of the Federal Reserve meeting [1] Group 1: Market Performance - The S&P 500 index opened at approximately 6,875.33, reflecting a 0.20% increase from the previous close [1] - The Nasdaq index rose by 0.30%, reaching 23,664.14 at the open [1]
Yardeni ends 15-year bullish call on Magnificent 7 as concentration risks climb
Invezz· 2025-12-08 14:29
Core Viewpoint - Yardeni Research has revised its long-standing overweight position on the Magnificent 7, indicating that the dominance of the largest American technology stocks has reached levels that are challenging to sustain [1] Group 1 - The Magnificent 7 refers to the seven largest technology companies in the U.S., which have significantly influenced market performance [1] - The decision to downgrade the stance reflects concerns over the sustainability of the growth and market dominance of these tech giants [1] - The shift in perspective may signal a broader market adjustment as investors reassess the valuations of these leading technology stocks [1]